Correlation Between ADMA Biologics and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ADMA Biologics and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADMA Biologics and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ADMA Biologics and Corvus Pharmaceuticals, you can compare the effects of market volatilities on ADMA Biologics and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADMA Biologics with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADMA Biologics and Corvus Pharmaceuticals.
Diversification Opportunities for ADMA Biologics and Corvus Pharmaceuticals
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between ADMA and Corvus is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding ADMA Biologics and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and ADMA Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADMA Biologics are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of ADMA Biologics i.e., ADMA Biologics and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between ADMA Biologics and Corvus Pharmaceuticals
Given the investment horizon of 90 days ADMA Biologics is expected to generate 2.98 times less return on investment than Corvus Pharmaceuticals. But when comparing it to its historical volatility, ADMA Biologics is 1.04 times less risky than Corvus Pharmaceuticals. It trades about 0.1 of its potential returns per unit of risk. Corvus Pharmaceuticals is currently generating about 0.27 of returns per unit of risk over similar time horizon. If you would invest 410.00 in Corvus Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 483.00 from holding Corvus Pharmaceuticals or generate 117.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ADMA Biologics vs. Corvus Pharmaceuticals
Performance |
| Timeline |
| ADMA Biologics |
| Corvus Pharmaceuticals |
ADMA Biologics and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ADMA Biologics and Corvus Pharmaceuticals
The main advantage of trading using opposite ADMA Biologics and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADMA Biologics position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.| ADMA Biologics vs. Atara Biotherapeutics | ADMA Biologics vs. Fate Therapeutics | ADMA Biologics vs. Sana Biotechnology | ADMA Biologics vs. Caribou Biosciences |
| Corvus Pharmaceuticals vs. Mereo BioPharma Group | Corvus Pharmaceuticals vs. Terns Pharmaceuticals | Corvus Pharmaceuticals vs. PDS Biotechnology Corp | Corvus Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |